跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
D-2-27
首页
药物
D-2-27
D-2-27
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GLP-1/GCG/GIP TRIPLE-RECEPTOR AGONIST AND USE THEREOF
EP 4596574 A1
申请人: SUNSHINE LAKE PHARMA CO LTD
优先权: 2022
CN
EP
WO
4 件公开
Hair cleansing composition
US 7776806 B2
申请人: KAO CORP
优先权: 2005
EP
US
3 件公开
Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
US 6987194 B2
申请人: FMC CORP
优先权: 2004
US
3 件公开
Heavy metal reduction in planta
US 9528118 B2
申请人: BOVET LUCIEN
优先权: 2010
CN
US
2 件公开
COMBINATION PRODUCTS FOR THE TREATMENT OF RSV
EP 3892273 A3
申请人: JANSSEN SCIENCES IRELAND UNLIMITED CO
优先权: 2016
EP
US
2 件公开
Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
US 2007112077 A1
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2006
US
2 件公开
Application of one or more of Aspergillus fumigatus allergen component and detection reagent for specific IgE of Aspergillus fumigatus allergen component in preparation of ABPA detection product, and ABPA detection product
CN 121995064 A
申请人: GUANGZHOU NAT LABORATORY
优先权: 2026
CN
2 件公开
Leukotriene B4 derivatives, in particular oximo-LTB4- antagonists
US 6160012 A
申请人: SCHERING AG
优先权: 1997
US
Method of inactivating viruses
EP 1053754 B1
申请人: ZLB BEHRING GMBH
优先权: 1999
EP
COSMETIC COMPOSITION COMPRISING AT LEAST A NON-POLYMERIC CRYSTALLINE SALT
WO 0172267 A1
申请人: OREAL
优先权: 2000
WO
第 1 / 5 页
上一页
下一页
药物
反馈